Lidocaine Jet Injector

Brand(s)
Zingo
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Powder Pharmaceuticals Inc. (2013-11-01)
Oldest Current Product
2015-01-05
License(s)
NDA
RxNORM
JET INJECTOR\LIDOCAINE
FDAOB
INTRADERMAL\SYSTEM\LIDOCAINE HYDROCHLORIDE\rdfq
SPL Active
INTRADERMAL\POWDER\LIDOCAINE HYDROCHLORIDE
SPL Moiety
INTRADERMAL\POWDER\LIDOCAINE

product(s) by strength(s)

lidocaine hydrochloride 0.5 mg jet injector

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1613880001ZingoNDAPowder Pharmaceuticals Inc.2015-01-05LIDOCAINE HYDROCHLORIDEINTRADERMALPOWDERNDA022114ea5416d6-5988-413b-8682-6835b359eb78

application(s)

#idtitleapplicantapprovedpatentapproved drug
1NDA022114ZINGOPOWDER PHARMACEUTICALS INC2007-08-16p6004286, SUBSTANCE
p6881200, SUBSTANCE
p8540665, ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
p5899880, SUBSTANCE
NDA022114_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routerldapprovedapplication
1NDA022114_001RXLIDOCAINE HYDROCHLORIDE (0.5MG)INTRADERMALFalse2007-08-16ZINGO

patent(s)

#idexpiration dateapplication(s)
1p5899880 (view patent)2016-05-04NDA022114
2p6004286 (view patent)2017-03-17NDA022114
3p6881200 (view patent)2016-06-11NDA022114
4p8540665 (view patent)2029-10-22NDA022114

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
1c913688b-c51d-44c2-8ce6-5200f1ea0bab (view SPL)These highlights do not include all the information needed to use Zingo safely and effectively. See full prescribing information for Zingo. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 1948prescriptionHuman PrescriptionMedline Industries, Inc.2014-11-132533290200
2ea5416d6-5988-413b-8682-6835b359eb78 (view SPL)These highlights do not include all the information needed to use Zingo safely and effectively. See full prescribing information for Zingo. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 1948prescriptionHuman PrescriptionPowder Pharmaceuticals Inc.2013-11-012613880001

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII